Skip to main contentSkip to navigation

GlaxoSmithKline

July 2024

  • Nils Pratley

    Nils Pratley on finance
    GSK’s health is improving. Shame about the legal heartburn

    Nils Pratley
    Emma Walmsley’s overhaul seems to be delivering the goods even if US worries have left the share price becalmed

March 2024

  • Emma Walmsley smiles as she sits by a window

    GlaxoSmithKline boss’s pay package jumps 50% to £12.7m

    Emma Walmsley’s deal, with a high share bonus payout, makes her one of top-paid CEOs in FTSE 100

September 2023

  • GSK logo

    People with HIV offered hope of self-injected drug at home

    GSK-controlled company works on developing patient-administered treatment by end of the decade

August 2023

  • Boats anchored in the River Thames, with buildings in the City of London financial district behind them

    FTSE 100 bosses ‘given average pay rise of £500,000 in 2022’

    CEOs received average increase of 16% while pay of many working for them failed to keep up with inflation

July 2023

  • Person in blue gloves preparing vaccine shot

    RSV vaccine for older adults approved by UK medicines regulator

    Arexvy could help NHS deal with virus that causes about 8,000 deaths among older people in UK each year

June 2023

  • A woman with her face painted with lungs and the words 'stop TB'.

    Fair Access
    ‘Gamechanging’ TB vaccine within reach after $500m pledge to run final trials

    Joint deal between Gates Foundation and Wellcome to develop M72 jab could save 8.5 million lives and prevent 76 million cases

April 2023

  • Rain Newton-Smith

    New CBI boss says she is ‘profoundly sorry’ to women let down by group

  • A company logo is seen at the AstraZeneca site in Macclesfield

    AstraZeneca overtakes Pfizer as crunch week for UK pharma looms

February 2023

  • Nils Pratley

    Nils Pratley on finance
    Take AstraZeneca’s warning seriously. The UK is missing out in life sciences

    Nils Pratley
  • Emma Walmsley, pictured arriving for a meeting in Downing Street in 2017,

    GSK boss warns UK life sciences at ‘tipping point’ despite Sunak’s R&D pledge

December 2022

  • Nils Pratley

    Nils Pratley on finance
    Moonpig flotation price, like so many, was always pie-in-the-sky thinking

    Nils Pratley
  • GlaxoSmithKline headquarters britain

    GSK shares surge as US judge dismisses Zantac cancer claims

November 2022

  • Nils Pratley

    Nils Pratley on finance
    Mark Zuckerberg’s metaverse is a joke not shared by investors

    Nils Pratley
    Meta’s share price is down 73% in 2022 but Facebook investors can’t force the boss to change course

October 2022

  • Labour's shadow health secretary, Wes Streeting, the shadow business secretary, Jonathan Reynolds, and the GSK chairman, Sir Jon Symonds, at the GSK lab in Stevenage.

    ‘A better partner’: Labour woos big business in bid to oust Rishi Sunak

    Wes Streeting and Jonathan Reynolds test water with pharma firm GSK as party prepares for election

September 2022

  • Nils Pratley

    Nils Pratley on finance
    The only party not getting heartburn over GSK demerger is the lawyers

    Nils Pratley
    The depressing outcome of the split is a legal challenge in the US over Zantac that will run on for years

July 2022

  • Nils Pratley

    Nils Pratley on finance
    Haleon’s debut suggests it may not be the jewel in GSK’s medicine cabinet

    Nils Pratley
    Consumer goods spin-off makes few waves in biggest European listing for more than a decade
  • GSK spin-off Haleon begins trading on the London Stock Exchange

    GSK spin-off Haleon begins trading in biggest European listing in a decade

    Consumer health company ends first day on London Stock Exchange with £28.5bn market valuation
  • GSK consumer products boast Sensodyne toothpaste and Panadol paracetamol

    London stock market listing of up to £45bn looms as GSK investors vote for demerger

    UK pharmaceutical firm to spin off Haleon – which will include brands such as Sensodyne and Panadol – in largest listing since 2011

May 2022

  • GP Appointments survey<br>File photo dated 10/09/14 of a stethoscope on top of patient's files, as only one in 10 patients using an online system actually requests to see their GP face-to-face, according to study of more than 7.5 million records. PA Photo. Issue date: Friday March 18, 2022. The new data, from experts at the Health Foundation working in partnership with NHS England, found that most patients were happy with telephone calls. See PA story HEALTH GPs. Photo credit should read: Anthony Devlin/PA Wire

    Hundreds of organisations breached patient data rules, reveals BMJ

  • A box of Piriton allergy tablets

    Boots, Superdrug and other chemists report hay fever pill shortages

About 945 results for GlaxoSmithKline
1234...
  翻译: